Study record

Peripheral Administration of a Cell-Penetrating MOTS-c Analogue Enhances Memory and Attenuates Aβ1-42- or LPS-Induced Memory Impairment through Inhibiting Neuroinflammation

Jiang J, Chang X, Nie Y et al. · ACS Chem Neurosci · 2021

AnimalSeveralEvidence tier C

What this study reported

Reported that centrally administered MOTS-c increased object and location recognition memory formation and consolidation in animals and reduced memory deficits induced by amyloid-beta or LPS, with the effect blocked by an AMPK inhibitor. MOTS-c given peripherally did not cross the blood-brain barrier, whereas a cell-penetrating MOTS-c analogue given intranasally or intravenously reached the brain and was associated with memory performance changes.

Limitations

Species and group sizes are not stated in the abstract, behavioural outcomes are short-term recognition tasks in acutely induced deficit models, and the analogue results rest on imaging-based biodistribution without blinding details.

Study record

Annotated fields for this study
Study modelAnimal study (in vivo)
Substance studiedSeveralMore than one of these is central to the paper (common for reviews).
SpeciesNot reported
System studiedRodent memory models with central MOTS-c and with a cell-penetrating MOTS-c analogue; species not specified in the abstract
PopulationNot reported
DesignControlled animal experiment
Sample size as reportedNot reported
Control groupvehicle-treated animals and AMPK-inhibitor comparison groups
Route (data field only)other
Endpoints measuredobject and location recognition memory; AMPK phosphorylation; astrocyte and microglial activation; proinflammatory cytokines; brain biodistribution
Pathways measuredAMPK signalling · Inflammation
Research areasNervous system · Inflammation & immunity
Evidence tierC — Animal in vivo
Publication typesJournal Article, Research Support, Non-U.S. Gov't

Appraisal

Each dimension is recorded separately and never combined into a single score. A study can be well controlled and still tell you little about people.

Relevance to MOTS-c
Direct
Model applicability
Mammalian
Sample size
Not reported
Controls
Appropriate
Outcome validity
Surrogate
Support for its own conclusion
Moderate

Provenance

  • Bibliographic fields retrieved from PubMed E-utilities efetch (title, journal, date, authors, DOI) on 2026-11-11.
  • Annotated from the published abstract.
  • Editorial review: approved (2026-11-11).
  • Classification follows the site methodology; the record describes the study, not what MOTS-c does in people.